Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
Study reveals links between global food systems, obesity, and climate change- What to know about voluntary chocolate recall
- Former IRGC child executioner tells ‘Post’ how he became devout Christian dissident
- FDA approves Wegovy pill for weight loss: What to know
- Treason trial of South Sudan's suspended VP is further eroding peace deal, UN experts say
- Experience Is standing by: History's Most noteworthy Travelers
- Pedal Power: Divulging Well known Bike Brands for Each Cyclist
- South America's Memorable Destinations: A Movement Guide
- Image of foreigners being arrested in S.Africa during Eid is AI-generated
